Patents Examined by Michael Barker
  • Method for obtaining a diglycoside-enriched extract, and use thereof in cosmetics
    Patent number: 11357719
    Abstract: Disclosed are a method for preparing a hydroalcoholic extract obtained from a biomass of the shoots of a plant from the family of Plumbaginaceae, a butanol extract of Armenia maritima, a method for the preparation thereof, the use thereof, and compositions containing same.
    Type: Grant
    Filed: June 15, 2017
    Date of Patent: June 14, 2022
    Assignees: BIOTECHMARINE, SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, L'UNIVERSITE DE STRASBOURG
    Inventors: Lorène Gourguillon, Laetitia Cattuzzato
  • Therapeutic composition comprising botanical extracts
    Patent number: 11351211
    Abstract: The present invention relates to a composition comprising a mixed alcoholic extract of eighteen botanical ingredients formulated into capsules for the treatment of H1N1 flu, strep, pneumonia, and Covid-19.
    Type: Grant
    Filed: September 21, 2020
    Date of Patent: June 7, 2022
    Inventor: Kelly Allen Buchanan
  • Herbal nanoformulations for treating psoriasis and other skin conditions
    Patent number: 11344598
    Abstract: A medicinal composition includes an active herbal component that is prepared by cooking a combination of Sheng Di Huang, Da Huang and Jin Yin Hua and has an average particulate size between 100-300 nm. Example formulations include topical gels, tablets and capsules.
    Type: Grant
    Filed: March 27, 2017
    Date of Patent: May 31, 2022
    Assignee: Sirbal Limited
    Inventors: Nadav Shraibom, Eran Steinberg, Manu Jaggi, Anu T. Singh, Ritu Verma, Alka Madaan
  • Compositions and methods for treating neurodegenerative diseases
    Patent number: 11319306
    Abstract: Compounds, and compositions, methods, and uses thereof, are described herein for treating neurodegenerative diseases and disorders. In particular, vasopressin receptor modulators, and compositions, methods and uses thereof, are described herein for treating neuropsychiatric aspects of neurodegenerative diseases such as Huntington's Disease, Parkinson's Disease, and Alzheimer's Disease.
    Type: Grant
    Filed: June 10, 2019
    Date of Patent: May 3, 2022
    Assignee: Azevan Pharmaceuticals, Inc.
    Inventor: Michael J. Brownstein
  • Active ingredient obtained from for the treatment of atopic dermatitis
    Patent number: 11311596
    Abstract: Methods of treatment for atopic dermatitis in a human subject or animal, the methods comprising administering topically to the human subject or animal an active ingredient obtained from Ophiopogon japonicus.
    Type: Grant
    Filed: January 12, 2017
    Date of Patent: April 26, 2022
    Assignee: SOCIETE INDUSTRIELLE LIMOUSINE D'APPLICATION BIOLOGIQUE
    Inventor: Jean Paufique
  • Water soluble formulation
    Patent number: 11298336
    Abstract: A formulation for solubilizing a water insoluble pharmaceutical agent is provided. The formulation comprises: a water-insoluble pharmaceutical agent, a detergent, an enzyme that breaks down lipids, proteins, and/or starches, a plasticizing agent, an emulsifying agent and an aqueous solvent. A method of making the formulation is also provided.
    Type: Grant
    Filed: May 30, 2019
    Date of Patent: April 12, 2022
    Assignee: Soluble Technologies, Inc.
    Inventor: Pankaj Modi
  • Topical skin health improvement compositions and administrations thereof
    Patent number: 11298391
    Abstract: In various implementations, a skin therapeutic may be topically applied to improve skin health. The skin therapeutic may decrease inflammation, decrease redness, and/or decrease health times. The skin therapeutic may include a composition that includes two or more of Brassica olearacea italica Seed Oil, bisabolol, and/or Zingiber officinales.
    Type: Grant
    Filed: April 27, 2018
    Date of Patent: April 12, 2022
    Assignee: Lorenol Laboratories, Inc.
    Inventor: Laura Montry
  • Water-soluble cannabinoids and methods of making same
    Patent number: 11291700
    Abstract: A process is provided for improving the water solubility of cannabinoids by combining cannabinoids with fat globules obtained from animals, plants, or synthetic chemistry. The animals can be mammals or non-mammals. The plants can be whole plants, tissue cultures, or genetically engineered plants. The fat globules can be used in their natural environment, and/or following processing, and/or as separated or purified particles.
    Type: Grant
    Filed: December 5, 2018
    Date of Patent: April 5, 2022
    Assignee: Nature's Delivery System, LLC
    Inventors: James F. Kane, Keith Butler
  • Composition based on nordihydroguaiaretic acid
    Patent number: 11278026
    Abstract: The pesticide and method of manufacturing includes one component extracted from an evergreen Bush “Larrea tridentate” the common name of which is Gobernadora, in which the main active ingredient is nordihydroguaiaretic acid(NDGA) 1,4-Bis(3,4-dihydroxyphenyl)-2,3-dimethylbutane, 4,4?-(2,3-Dimethyltetramethylene) dipyrocatechol. The composition of which is enriched with plant oils, emulsifiers and humidifiers, thus obtaining a product which can be easily used in crops with the help of sprinklers. Consequently, the action field of this procedure is within chemical compositions used to cultivate crops and fruit products.
    Type: Grant
    Filed: November 24, 2019
    Date of Patent: March 22, 2022
    Assignee: PROMOTORA TECNICA INDUSTRIAL, S.A. DE C.V.
    Inventors: Mario Saavedra Aguilar, Odon Vite Vallejo
  • Chitin and chitosan producing methods
    Patent number: 11279962
    Abstract: The invention relates to the field of polymer production, in particular to the production of chitin and chitosan from microalgae belonging to the phylum Haptophyta to the phylum Chlorophyta, or to the phylum Heterokontophyta, particularly from microalgae of the genus Isochrysis, Chlorella, Bracteacoccus, Chlorococcum, Scenedesmns, Desmodesmus, Haematococcus, Thalassiosira and Nannochloropsis, as well as to microalgal extracts thereof and their uses.
    Type: Grant
    Filed: December 16, 2015
    Date of Patent: March 22, 2022
    Assignee: Algaktiv, S.L.
    Inventors: Derek Georges Latil De Ros, María Teresa López Cerro, Eugenia Ruiz Canovas, Olga Durany Turk, Jordi Segura De Yebra, Jaume Mercadé Roca, Daniel Pérez Reyes, Xavier Álvarez Mico
  • Pharmaceutical compositions with enhanced permeation
    Patent number: 11273131
    Abstract: Pharmaceutical compositions having enhanced active component permeation properties are described.
    Type: Grant
    Filed: October 3, 2017
    Date of Patent: March 15, 2022
    Assignee: AQUESTIVE THERAPEUTICS, INC.
    Inventors: Alexander Mark Schobel, Stephanie Marie Varjan, Stephen Paul Wargacki
  • Administering compositions for improved immune system functioning
    Patent number: 11273191
    Abstract: The present disclosure relates to methods of administering a composition to a patient, particularly in the form of a dietary supplement, which addresses immune system deficiencies and promotes healthy immune system functioning. The present disclosure also related to compositions and methods for improving or boosting immune system functioning. The present disclosure further provides novel compositions for balancing immune response in human subjects.
    Type: Grant
    Filed: March 30, 2020
    Date of Patent: March 15, 2022
    Assignee: Script Essentials, LLC
    Inventor: Suzy Cohen
  • Dietary supplement compositions
    Patent number: 11273195
    Abstract: This document provides dietary supplement compositions. For example, dietary supplement compositions having an acetylcholinesterase inhibitor (e.g., huperzine A), a Bacopa monnieri extract, acetyl-L-carnitine or acetyl CoA, and a curcuminoid (e.g., curcumin) are provided.
    Type: Grant
    Filed: November 21, 2018
    Date of Patent: March 15, 2022
    Assignee: Melaleuca, Inc.
    Inventors: Alexander B. Rabovsky, Stephanie Y. Nielson
  • Urea derivative or pharmacologically acceptable salt thereof
    Patent number: 11261155
    Abstract: Provided is a compound having a formyl peptide receptor like 1 (FPRL1) agonist effect. The present invention relates to a compound represented by the general formula (I) or a pharmacologically acceptable salt thereof. The present invention also relates to a pharmaceutical composition containing the compound represented by the general formula (I) or a pharmacologically acceptable salt thereof.
    Type: Grant
    Filed: May 21, 2020
    Date of Patent: March 1, 2022
    Assignee: Kyorin Pharmaceutical Co., Ltd.
    Inventors: Hiroyasu Takahashi, Yoshifumi Saito, Kosuke Tsuda, Mitsuhito Shibasaki, Kohei Ohata
  • Oat fractions with enhanced Avenanthramide concentration and methods of making
    Patent number: 11260037
    Abstract: Exemplary embodiments provide oat fractions, and methods of producing the oat fractions, of the species Avena Sativa that has a concentration of total Avenanthramides that is from about 2 to about 25 wt. %, and up to about 30 wt. % or more, higher than the concentration before treatment with infrared energy. The higher concentration is achieved without treatment with enzymes or exposure to fungal agents to increase the concentration of total Avenanthramides. Instead, the enhanced concentration of Avenanthramides is achieved through exposure to infrared energy for a selected period of time.
    Type: Grant
    Filed: May 9, 2019
    Date of Patent: March 1, 2022
    Assignee: The Quaker Oats Company
    Inventors: YiFang Chu, Jodee Johnson, Marianne O'Shea
  • Topical compositions and methods for reducing oxidative stress
    Patent number: 11260020
    Abstract: Compositions for reducing skin aging resulting from oxidative stress and/or photodamage are disclosed herein. The compositions can be topically applied to a skin region to reduce or prevent skin wrinkles, fine lines, thinning skin, sagging skin, skin dryness, and skin itchiness.
    Type: Grant
    Filed: April 30, 2014
    Date of Patent: March 1, 2022
    Assignee: Kimberly-Clark Worldwide, Inc.
    Inventors: Lucia Piccotti, David J. Tyrrell, Penkanok Sriwiriyanont, Debbie Ngai, Josh Gregorio, Scott W. Wenzel, Rebecca Uelmen, Seungjun ‘Jason’ Lee
  • Anticancer drug effect enhancer
    Patent number: 11246847
    Abstract: The present invention relates to a pharmaceutical composition comprising a citrate salt for use in enhancing the effect of an anticancer drug.
    Type: Grant
    Filed: February 5, 2020
    Date of Patent: February 15, 2022
    Assignee: Delta-Fly Pharma, Inc.
    Inventors: Hiromi Wada, Tatsuhiro Ishida, Kiyoshi Eshima
  • Synergistic extract of and jasmine, compositions comprising same and uses thereof
    Patent number: 11247077
    Abstract: The present invention relates to a synergistic extract of Palmaria palmata and of jasmine flower heads, obtained after aqueous extraction of Palmaria palmata, in which maceration of the jasmine flower heads is then carried out, the ratio of the dry weight of Palmaria palmata to the dry weight of the flower heads being between 40/60 and 95/5. The present invention also relates to a method for obtaining said synergistic extract and cosmetic compositions comprising said extract as an active agent. The invention finally relates to the cosmetic use of said composition for combating the signs of aging and for improving the elasticity of the skin, by favoring maintenance of the “stem” character of the adult dermal stem cells (SKPs).
    Type: Grant
    Filed: November 4, 2016
    Date of Patent: February 15, 2022
    Assignees: ISP INVESTMENTS LLC, LVMH RECHERCHE
    Inventors: Valérie Lequoy, Frédérique Portolan, Audrey Le Mestr, Christophe Capallere, Isabelle Imbert, Joël Mantelin, Jean Marie Botto, Nouha Domloge, Noëlle Garcia, Carine Nizard, Laurine Bergeron
  • Fast-acting plant-based medicinal compounds and nutritional supplements
    Patent number: 11246852
    Abstract: Plant-based medicinal compounds or nutritional supplements in various carrier combinations are described. The carriers can include N-acylated fatty amino acids, penetration enhancers, and/or various other beneficial carriers. The plant-based composition/carrier combinations can create administration benefits.
    Type: Grant
    Filed: October 6, 2017
    Date of Patent: February 15, 2022
    Assignee: Receptor Holdings, Inc.
    Inventors: Andrea Leone-Bay, Gregory Wesner
  • Anti-inflammatory, analgesic and fast-healing external traditional Chinese medicine preparation and its preparation method
    Patent number: 11246900
    Abstract: The present invention provides an anti-inflammatory, analgesic and fast-healing external traditional Chinese medicine preparation and its preparation method. The traditional Chinese medicine preparation includes following components in parts by weight: 30-80 parts of corydalis tuber, 20-90 parts of maifanitum, 20-50 parts of radix aconiti kusnezoffii praeparata, 10-45 parts of common clubmoss herb, 10-40 parts of clematis root, 10-40 parts of safflower, 5-40 parts of bryozoatum and 5-35 parts of oyster shell. The traditional Chinese medicine preparation has advantages of unique prescription, reasonable ratio, advanced preparation process, high active ingredient content, fast absorption, no irritation of ethanol preparation to the skin, convenient use, direct effect on the lesion location, fast and significant curative effect and no adverse effect on organs of the human body.
    Type: Grant
    Filed: June 6, 2017
    Date of Patent: February 15, 2022
    Inventor: Cuilin Yi